Skip Navigation


Rheumatology Advance Access originally published online on April 14, 2008
Rheumatology 2008 47(6):914-919; doi:10.1093/rheumatology/ken107
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/6/914    most recent
ken107v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mandl, T.
Right arrow Articles by Jacobsson, L. T. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandl, T.
Right arrow Articles by Jacobsson, L. T. H.
Related Collections
Right arrow Sjogren's Syndrome
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Autonomic nervous symptoms in primary Sjögren's; syndrome

T. Mandl1, V. Granberg2, J. Apelqvist2, P. Wollmer3, R. Manthorpe4 and L. T. H. Jacobsson1

1Department of Rheumatology, 2Department of Endocrinology, 3Department of Clinical Physiology, Malmö University Hospital and 4Sjögren's Syndrome Research Centre, Malmö, Sweden.

Correspondence to: T. Mandl, Department of Rheumatology, Ing 25 plan 2, Malmö University Hospital, S-205 02 Malmö, Sweden. E-mail: thomas.mandl{at}med.lu.se


   Abstract

Objectives. Objective signs of autonomic dysfunction (AD) have been reported in patients with primary SS (pSS) while the presence of associated symptoms has not been systematically studied. Therefore, the aims of this study were (i) to assess the presence and severity of various AD symptoms in pSS patients and (ii) to relate AD symptoms to other clinical features of pSS.

Methods. Thirty-eight pSS patients and 200 population-based controls were studied for presence and severity of AD symptoms using the Autonomic Symptom Profile (ASP), a validated self-completed questionnaire evaluating various AD symptoms. In addition, patients were investigated by three different objective autonomic nervous function tests.

Results. pSS patients scored significantly higher in the parasympathetic [secretomotor disorder, urinary disorder, gastroparesis (females only) and pupillomotor disorder] as well as sympathetic (orthostatic intolerance and vasomotor disorder) ASP domains compared with controls. Consequently, the standardized ASP total score was significantly increased in pSS patients [1.77 (0.57, 3.15) vs – 0.21 (–0.82, 0.72); P = 0.00] and 45% of pSS patients had an ASP total score ≥2 S.D. Furthermore, the autonomic nervous function tests showed signs of objective parasympathetic and sympathetic dysfunction as well. However, the ASP domain and total scores showed limited associations with the objective autonomic nervous function test parameters as well as clinical and serological factors of pSS.

Conclusions. pSS patients showed subjective and objective signs of both a parasympathetic and a sympathetic dysfunction. However, AD symptoms showed limited associations with objective autonomic nervous function as well as other clinical features of the disease.

KEY WORDS: Autonomic symptoms, Primary Sjögren's; syndrome, Cardiovascular, Nervous, Physiology

Submitted 21 November 2007; revised version accepted 13 February 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.